TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biolink Group AS
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
1,060
|
1,777
|
5,304 |
| Financial expenses |
1,721
|
1,571
|
1,302 |
| Earnings before taxes |
-9,311
|
-11,326
|
-12,679 |
| Total assets |
71,057
|
70,826
|
88,651 |
| Current assets |
7,483
|
9,578
|
27,105 |
| Current liabilities |
7,598
|
3,567
|
3,859 |
| Equity capital |
35,144
|
41,495
|
55,862 |
| - share capital |
5,809
|
5,914
|
6,334 |
| Employees (average) | 4 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
49.5%
|
58.6%
|
63.0% |
| Turnover per employee | 265 | ||
| Profit as a percentage of turnover |
-878.4%
|
-637.4%
|
-239.0% |
| Return on assets (ROA) |
-10.7%
|
-13.8%
|
-12.8% |
| Current ratio |
98.5%
|
268.5%
|
702.4% |
| Return on equity (ROE) |
-26.5%
|
-27.3%
|
-22.7% |
| Change turnover |
-686
|
-3,176
|
-648 |
| Change turnover % |
-39%
|
-64%
|
-11% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.